VISTAGEN THERAPEUTICS, INC. Research and Development Expense
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Research and Development Expense of $10.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- VISTAGEN THERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $10.91M, a 6.61% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $13.06M, a 27.95% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $14.22M, a 25.81% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $15.91M, a 55.80% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. research and development expense for fiscal 2026 was $54.97M, a 39.62% increase from fiscal 2025.
- VISTAGEN THERAPEUTICS, INC. research and development expense for fiscal 2025 was $39.38M, a 96.66% increase from fiscal 2024.
- VISTAGEN THERAPEUTICS, INC. research and development expense for fiscal 2024 was $20.02M, a 54.88% decline from fiscal 2023.
- VISTAGEN THERAPEUTICS, INC. research and development expense for fiscal 2023 was $44.38M, a 25.33% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 157 month | Research and Development Expense 160 month | Research and Development Expense 163 month | Research and Development Expense 166 month | Research and Development Expense 169 month | Research and Development Expense 172 month | Research and Development Expense 175 month | Research and Development Expense 178 month | Research and Development Expense 181 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.91M 10-Q · filed 2026-08-14 | $23.97M derived: sum of 2 quarters · filed 2026-08-14 | $38.19M derived: sum of 3 quarters · filed 2026-08-14 | $54.10M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2026-03-31 | $13.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | $27.28M derived: sum of 2 quarters · filed 2026-06-15 | $43.20M derived: sum of 3 quarters · filed 2026-06-15 | $54.97M 10-K · filed 2026-06-15 | |||||||||||||
| 2025-12-31 | $14.22M 10-Q · filed 2026-02-12 | $30.14M derived: sum of 2 quarters · filed 2026-02-12 | $41.91M 10-Q · filed 2026-02-12 | $52.02M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-09-30 | $15.91M 10-Q · filed 2025-11-13 | $27.69M 10-Q · filed 2025-11-13 | $37.80M derived: sum of 3 quarters · filed 2026-08-14 | $49.10M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-06-30 | $11.68M 10-Q · filed 2026-08-14 | $21.89M derived: sum of 2 quarters · filed 2026-08-14 | $33.19M derived: sum of 3 quarters · filed 2026-08-14 | $43.41M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||||
| 2025-03-31 | $10.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | $21.51M derived: sum of 2 quarters · filed 2026-06-15 | $31.73M derived: sum of 3 quarters · filed 2026-06-15 | $39.38M 10-K · filed 2026-06-15 | |||||||||||||
| 2024-12-31 | $11.30M 10-Q · filed 2026-02-12 | $21.52M derived: sum of 2 quarters · filed 2026-02-12 | $29.17M 10-Q · filed 2026-02-12 | $36.60M derived: sum of 4 quarters · filed 2026-02-12 | |||||||||||||
| 2024-09-30 | $10.21M 10-Q · filed 2025-11-13 | $17.86M 10-Q · filed 2025-11-13 | $25.30M derived: sum of 3 quarters · filed 2025-11-13 | $29.84M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||||||
| 2024-06-30 | $7.65M 10-Q · filed 2025-08-07 | $15.08M derived: sum of 2 quarters · filed 2025-08-07 | $19.62M derived: sum of 3 quarters · filed 2025-08-07 | $23.47M derived: sum of 4 quarters · filed 2025-08-07 | |||||||||||||
| 2024-03-31 | $7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $11.97M derived: sum of 2 quarters · filed 2025-06-17 | $15.82M derived: sum of 3 quarters · filed 2025-06-17 | $20.02M 10-K · filed 2025-06-17 | |||||||||||||
| 2023-12-31 | $4.54M 10-Q · filed 2025-02-13 | $4.54M 10-Q · filed 2024-02-13 | $8.39M derived: sum of 2 quarters · filed 2025-02-13 | $12.59M 10-Q · filed 2025-02-13 | $12.59M 10-Q · filed 2024-02-13 | $21.92M derived: sum of 4 quarters · filed 2025-02-13 | |||||||||||
| 2023-09-30 | $3.85M 10-Q · filed 2024-11-07 | $3.85M 10-Q · filed 2023-11-09 | $8.05M 10-Q · filed 2024-11-07 | $8.05M 10-Q · filed 2023-11-09 | $17.39M derived: sum of 3 quarters · filed 2024-11-07 | $24.24M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||
| 2023-06-30 | $4.20M 10-Q · filed 2024-08-13 | $4.20M 10-Q · filed 2023-08-10 | $13.53M derived: sum of 2 quarters · filed 2024-08-13 | $20.39M derived: sum of 3 quarters · filed 2024-08-13 | $33.28M derived: sum of 4 quarters · filed 2024-08-13 | ||||||||||||
| 2023-03-31 | $9.34M 10-K · filed 2023-06-28 | $16.19M derived: sum of 2 quarters · filed 2024-02-13 | $29.09M derived: sum of 3 quarters · filed 2024-02-13 | $44.38M 10-K · filed 2024-06-11 | $44.38M 10-K · filed 2023-06-28 | ||||||||||||
| 2022-12-31 | $6.85M 10-Q · filed 2024-02-13 | $19.75M derived: sum of 2 quarters · filed 2024-02-13 | $35.04M 10-Q · filed 2024-02-13 | $47.27M derived: sum of 4 quarters · filed 2024-02-13 | |||||||||||||
| 2022-09-30 | $12.89M 10-Q · filed 2023-11-09 | $28.19M 10-Q · filed 2023-11-09 | $40.42M derived: sum of 3 quarters · filed 2023-11-09 | $48.20M derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||||
| 2022-06-30 | $15.29M 10-Q · filed 2023-08-10 | $27.53M derived: sum of 2 quarters · filed 2023-08-10 | $35.30M derived: sum of 3 quarters · filed 2023-08-10 | $45.24M derived: sum of 4 quarters · filed 2023-08-10 | |||||||||||||
| 2022-03-31 | $12.23M 10-K · filed 2023-06-28 | $20.01M derived: sum of 2 quarters · filed 2023-06-28 | $29.95M derived: sum of 3 quarters · filed 2023-06-28 | $35.41M 10-K · filed 2023-06-28 | |||||||||||||
| 2021-12-31 | $7.78M 10-K · filed 2023-06-28 | $7.97M 10-Q · filed 2022-02-10 | $17.72M derived: sum of 2 quarters · filed 2023-06-28 | $23.17M 10-Q · filed 2023-02-07 | $23.64M 10-Q · filed 2022-02-10 | $28.07M derived: sum of 4 quarters · filed 2023-06-28 | |||||||||||
| 2021-09-30 | $9.94M 10-K · filed 2023-06-28 | $10.07M 10-Q · filed 2021-11-10 | $15.39M 10-Q · filed 2022-11-10 | $15.67M 10-Q · filed 2021-11-10 | $20.29M derived: sum of 3 quarters · filed 2023-06-28 | $23.78M derived: sum of 4 quarters · filed 2023-06-28 | |||||||||||
| 2021-06-30 | $5.46M 10-K · filed 2023-06-28 | $10.35M derived: sum of 2 quarters · filed 2023-06-28 | $13.85M derived: sum of 3 quarters · filed 2023-06-28 | $16.20M derived: sum of 4 quarters · filed 2023-06-28 | |||||||||||||
| 2021-03-31 | $4.89M 10-K · filed 2021-06-29 | $8.39M derived: sum of 2 quarters · filed 2022-02-10 | $10.75M derived: sum of 3 quarters · filed 2022-02-10 | $11.93M 10-K · filed 2022-06-23 | $12.48M 10-K · filed 2021-06-29 | ||||||||||||
| 2020-12-31 | $3.50M 10-Q · filed 2022-02-10 | $3.50M 10-K · filed 2021-06-29 | $5.85M derived: sum of 2 quarters · filed 2022-02-10 | $7.59M 10-Q · filed 2022-02-10 | $7.71M derived: sum of 4 quarters · filed 2022-02-10 | ||||||||||||
| 2020-09-30 | $2.36M 10-Q · filed 2021-11-10 | $2.36M 10-K · filed 2021-06-29 | $4.09M 10-Q · filed 2021-11-10 | $4.21M derived: sum of 3 quarters · filed 2021-11-10 | $7.23M derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||
| 2020-06-30 | $15.00K 10-Q · filed 2021-08-12 | $1.73M 10-K · filed 2021-06-29 | $1.85M derived: sum of 2 quarters · filed 2021-08-12 | $4.87M derived: sum of 3 quarters · filed 2021-08-12 | $9.07M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||
| 2020-03-31 | $1.84M 10-K · filed 2021-06-29 | $4.86M derived: sum of 2 quarters · filed 2021-06-29 | $9.06M derived: sum of 3 quarters · filed 2021-06-29 | $13.37M 10-K · filed 2021-06-29 | |||||||||||||
| 2019-12-31 | $3.02M 10-K · filed 2021-06-29 | $7.22M derived: sum of 2 quarters · filed 2021-06-29 | $11.53M derived: sum of 3 quarters · filed 2021-06-29 | $15.29M derived: sum of 4 quarters · filed 2021-06-29 | |||||||||||||
| 2019-09-30 | $4.21M 10-K · filed 2021-06-29 | $8.52M derived: sum of 2 quarters · filed 2021-06-29 | $12.28M derived: sum of 3 quarters · filed 2021-06-29 | $17.61M derived: sum of 4 quarters · filed 2021-06-29 | |||||||||||||
| 2019-06-30 | $4.31M 10-K · filed 2021-06-29 | $8.07M derived: sum of 2 quarters · filed 2021-06-29 | $13.41M derived: sum of 3 quarters · filed 2021-06-29 | $18.67M derived: sum of 4 quarters · filed 2021-06-29 | |||||||||||||
| 2019-03-31 | $3.76M 10-K · filed 2020-06-29 | $9.09M derived: sum of 2 quarters · filed 2020-06-29 | $14.35M derived: sum of 3 quarters · filed 2020-06-29 | $17.10M 10-K · filed 2020-06-29 | |||||||||||||
| 2018-12-31 | $5.33M 10-K · filed 2020-06-29 | $10.60M derived: sum of 2 quarters · filed 2020-06-29 | $13.34M derived: sum of 3 quarters · filed 2020-06-29 | $15.98M derived: sum of 4 quarters · filed 2020-06-29 | |||||||||||||
| 2018-09-30 | $5.26M 10-K · filed 2020-06-29 | $8.01M derived: sum of 2 quarters · filed 2020-06-29 | $10.64M derived: sum of 3 quarters · filed 2020-06-29 | $12.24M derived: sum of 4 quarters · filed 2020-06-29 | |||||||||||||
| 2018-06-30 | $2.74M 10-K · filed 2020-06-29 | $5.38M derived: sum of 2 quarters · filed 2020-06-29 | $6.98M derived: sum of 3 quarters · filed 2020-06-29 | $9.41M derived: sum of 4 quarters · filed 2020-06-29 | |||||||||||||
| 2018-03-31 | $2.64M 10-K · filed 2019-06-25 | $4.24M derived: sum of 2 quarters · filed 2019-06-25 | $6.67M derived: sum of 3 quarters · filed 2019-06-25 | $7.76M 10-K · filed 2019-06-25 | |||||||||||||
| 2017-12-31 | $1.60M 10-K · filed 2019-06-25 | $4.03M derived: sum of 2 quarters · filed 2019-06-25 | $5.13M derived: sum of 3 quarters · filed 2019-06-25 | $6.29M derived: sum of 4 quarters · filed 2019-06-25 | |||||||||||||
| 2017-09-30 | $2.43M 10-K · filed 2019-06-25 | $3.52M derived: sum of 2 quarters · filed 2019-06-25 | $4.68M derived: sum of 3 quarters · filed 2019-06-25 | $6.29M derived: sum of 4 quarters · filed 2019-06-25 | |||||||||||||
| 2017-06-30 | $1.10M 10-K · filed 2019-06-25 | $2.26M derived: sum of 2 quarters · filed 2019-06-25 | $3.87M derived: sum of 3 quarters · filed 2019-06-25 | $5.47M derived: sum of 4 quarters · filed 2019-06-25 | |||||||||||||
| 2017-03-31 | $1.16M 10-K · filed 2018-06-26 | $2.77M derived: sum of 2 quarters · filed 2018-06-26 | $4.38M derived: sum of 3 quarters · filed 2018-06-26 | $5.20M 10-K · filed 2018-06-26 | |||||||||||||
| 2016-12-31 | $1.61M 10-K · filed 2018-06-26 | $3.22M derived: sum of 2 quarters · filed 2018-06-26 | $4.04M derived: sum of 3 quarters · filed 2018-06-26 | $5.14M derived: sum of 4 quarters · filed 2018-06-26 | |||||||||||||
| 2016-09-30 | $1.61M 10-K · filed 2018-06-26 | $2.43M derived: sum of 2 quarters · filed 2018-06-26 | $3.53M derived: sum of 3 quarters · filed 2018-06-26 | $4.33M derived: sum of 4 quarters · filed 2018-06-26 | |||||||||||||
| 2016-06-30 | $826.00K 10-K · filed 2018-06-26 | $1.92M derived: sum of 2 quarters · filed 2018-06-26 | $2.73M derived: sum of 3 quarters · filed 2018-06-26 | $4.38M derived: sum of 4 quarters · filed 2018-06-26 | |||||||||||||
| 2016-03-31 | $1.10M 10-K · filed 2017-06-29 | $1.90M derived: sum of 2 quarters · filed 2017-06-29 | $3.56M derived: sum of 3 quarters · filed 2017-06-29 | $3.93M 10-K · filed 2017-06-29 | |||||||||||||
| 2015-12-31 | $806.00K 10-K · filed 2017-06-29 | $2.46M derived: sum of 2 quarters · filed 2017-06-29 | $2.83M derived: sum of 3 quarters · filed 2017-06-29 | $3.79M derived: sum of 4 quarters · filed 2017-06-29 | |||||||||||||
| 2015-09-30 | $1.66M 10-K · filed 2017-06-29 | $2.03M derived: sum of 2 quarters · filed 2017-06-29 | $2.98M derived: sum of 3 quarters · filed 2017-06-29 | $3.43M derived: sum of 4 quarters · filed 2017-06-29 | |||||||||||||
| 2015-06-30 | $373.00K 10-K · filed 2017-06-29 | $1.33M derived: sum of 2 quarters · filed 2017-06-29 | $1.77M derived: sum of 3 quarters · filed 2017-06-29 | $2.33M derived: sum of 4 quarters · filed 2017-06-29 | |||||||||||||
| 2015-03-31 | $956.00K 10-K · filed 2016-06-24 | $1.40M derived: sum of 2 quarters · filed 2016-06-24 | $1.96M derived: sum of 3 quarters · filed 2016-06-24 | $2.43M 10-K · filed 2016-06-24 | $2.43M 10-K · filed 2015-06-29 | ||||||||||||
| 2014-12-31 | $445.00K 10-K · filed 2016-06-24 | $1.00M derived: sum of 2 quarters · filed 2016-06-24 | $1.48M derived: sum of 3 quarters · filed 2016-06-24 | $2.04M derived: sum of 4 quarters · filed 2016-06-24 | |||||||||||||
| 2014-09-30 | $558.00K 10-K · filed 2016-06-24 | $1.03M derived: sum of 2 quarters · filed 2016-06-24 | $1.60M derived: sum of 3 quarters · filed 2016-06-24 | $2.15M derived: sum of 4 quarters · filed 2016-06-24 | |||||||||||||
| 2014-06-30 | $474.00K 10-K · filed 2016-06-24 | $1.04M derived: sum of 2 quarters · filed 2016-06-24 | $1.59M derived: sum of 3 quarters · filed 2016-06-24 | $2.26M derived: sum of 4 quarters · filed 2016-06-24 | |||||||||||||
| 2014-03-31 | $566.00K 10-K · filed 2015-06-29 | $1.12M derived: sum of 2 quarters · filed 2015-06-29 | $1.79M derived: sum of 3 quarters · filed 2015-06-29 | $2.48M 10-K · filed 2015-06-29 | |||||||||||||
| 2013-12-31 | $551.00K 10-K · filed 2015-06-29 | $1.22M derived: sum of 2 quarters · filed 2015-06-29 | $1.92M derived: sum of 3 quarters · filed 2015-06-29 | $2.25M derived: sum of 4 quarters · filed 2015-06-29 | |||||||||||||
| 2013-09-30 | $669.00K 10-K · filed 2015-06-29 | $1.36M derived: sum of 2 quarters · filed 2015-06-29 | $1.70M derived: sum of 3 quarters · filed 2015-06-29 | $2.82M derived: sum of 4 quarters · filed 2015-06-29 | |||||||||||||
| 2013-06-30 | $695.00K 10-K · filed 2015-06-29 | $695.50K 10-Q · filed 2013-08-14 | $1.03M derived: sum of 2 quarters · filed 2015-06-29 | $2.15M derived: sum of 3 quarters · filed 2015-06-29 | $3.26M derived: sum of 4 quarters · filed 2015-06-29 | $30.25M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $339.00K 10-K · filed 2014-06-25 | $1.46M derived: sum of 2 quarters · filed 2014-06-25 | $2.56M derived: sum of 3 quarters · filed 2014-06-25 | $3.43M 10-K · filed 2014-06-25 | $3.43M 10-K · filed 2013-07-18 | $29.56M 10-K · filed 2013-07-18 | |||||||||||
| 2012-12-31 | $1.12M 10-K · filed 2014-06-25 | $2.23M derived: sum of 2 quarters · filed 2014-06-25 | $3.09M 10-Q · filed 2013-02-14 | $4.92M derived: sum of 4 quarters · filed 2014-06-25 | $29.22M 10-Q · filed 2013-02-14 | ||||||||||||
| 2012-09-30 | $1.11M 10-K · filed 2014-06-25 | $1.11M 10-Q · filed 2012-11-14 | $1.97M 10-Q · filed 2012-11-14 | $3.80M derived: sum of 3 quarters · filed 2014-06-25 | $5.11M derived: sum of 4 quarters · filed 2014-06-25 | $28.10M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $866.00K 10-K · filed 2014-06-25 | $866.30K 10-Q · filed 2012-08-14 | $2.69M derived: sum of 2 quarters · filed 2014-06-25 | $4.00M derived: sum of 3 quarters · filed 2014-06-25 | $5.23M derived: sum of 4 quarters · filed 2014-06-25 | $26.99M 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $1.83M 10-K · filed 2013-07-18 | $3.13M derived: sum of 2 quarters · filed 2013-07-18 | $4.36M derived: sum of 3 quarters · filed 2013-07-18 | $5.39M 10-K · filed 2013-07-18 | $26.12M 10-K · filed 2012-07-02 | ||||||||||||
| 2011-12-31 | $1.31M 10-K · filed 2013-07-18 | $1.31M 10-Q · filed 2012-02-14 | $2.53M derived: sum of 2 quarters · filed 2013-07-18 | $3.56M 10-Q · filed 2013-02-14 | $3.56M 10-Q · filed 2012-02-14 | $5.43M derived: sum of 4 quarters · filed 2013-07-18 | $24.30M 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | $1.23M 10-K · filed 2013-07-18 | $1.23M 10-Q · filed 2011-11-14 | $2.26M 10-Q · filed 2012-11-14 | $2.26M 10-Q · filed 2011-11-14 | $4.12M derived: sum of 3 quarters · filed 2013-07-18 | $4.57M derived: sum of 4 quarters · filed 2013-07-18 | $22.99M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | $1.03M 10-K · filed 2013-07-18 | $1.03M 10-Q · filed 2011-08-22 | $2.89M derived: sum of 2 quarters · filed 2013-07-18 | $3.34M derived: sum of 3 quarters · filed 2013-07-18 | $4.03M derived: sum of 4 quarters · filed 2013-07-18 | $21.76M 10-Q · filed 2011-08-22 | |||||||||||
| 2011-03-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02 | $2.31M derived: sum of 2 quarters · filed 2012-07-02 | $3.00M derived: sum of 3 quarters · filed 2012-07-02 | $3.68M 10-K · filed 2012-07-02 | |||||||||||||
| 2010-12-31 | $446.81K 10-Q · filed 2012-02-14 | $1.14M derived: sum of 2 quarters · filed 2012-02-14 | $1.81M 10-Q · filed 2012-02-14 | ||||||||||||||
| 2010-09-30 | $691.92K 10-Q · filed 2011-11-14 | $1.37M 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | $674.78K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |